TRiCares Announces First Topaz Implantation in EU Pivotal Study TRiCares Announces First Topaz Implantation in EU Pivotal StudyParis, France and Munich, Germany, September 24, 2024 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid...

TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones Paris, France and Munich, Germany, July 25, 2024 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field...

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker Paris, France and Munich, Germany, December 21, 2023 –...